Literature DB >> 19921550

Pathologic complete response of a solitary melanoma brain metastasis after local ablative radiation therapy: case report.

Steven Register1, James W Clarke, Abhik Ray Chaudhury, Simon S Lo.   

Abstract

A 73-year-old female with malignant melanoma metastatic to her left frontal lobe status post-gross total resection of the metastasis, whole brain radiotherapy, and Gamma Knife-based stereotactic radiosurgery for local recurrence presented with an area of increasing enhancement on follow-up magnetic resonance imaging (MRI) and hypermetabolic lesions on 18-fluorodeoxyglucose positron emission tomography/computerized tomography (18FDG PET/CT) of the brain suspicious for tumor recurrence. Surgical resection of the lesion was performed showing radiation necrosis with no evidence of tumor. The patient was alive 1 year after her second craniotomy. This case illustrates that despite being perceived as a radioresistant histology, complete local eradication of melanoma is possible with ablative dose regimens. Prolonged survival is possible in patients with limited metastatic melanoma if local tumor control is achieved.

Entities:  

Mesh:

Year:  2009        PMID: 19921550     DOI: 10.1007/s12032-009-9360-3

Source DB:  PubMed          Journal:  Med Oncol        ISSN: 1357-0560            Impact factor:   3.064


  5 in total

1.  Brain metastases after stereotactic radiosurgery using the Leksell gamma knife: can FDG PET help to differentiate radionecrosis from tumour progression?

Authors:  Otakar Belohlávek; Gabriela Simonová; Iva Kantorová; Josef Novotný; Roman Liscák
Journal:  Eur J Nucl Med Mol Imaging       Date:  2002-11-05       Impact factor: 9.236

2.  Tumor-related prognostic factors for remission of brain metastases after radiotherapy.

Authors:  C Nieder; W Berberich; K Schnabel
Journal:  Int J Radiat Oncol Biol Phys       Date:  1997-08-01       Impact factor: 7.038

3.  The sensitivity and specificity of FDG PET in distinguishing recurrent brain tumor from radionecrosis in patients treated with stereotactic radiosurgery.

Authors:  S T Chao; J H Suh; S Raja; S Y Lee; G Barnett
Journal:  Int J Cancer       Date:  2001-06-20       Impact factor: 7.396

4.  A prospective Phase II trial of using extracranial stereotactic radiotherapy in primary and metastatic renal cell carcinoma.

Authors:  Christer Svedman; Per Sandström; Pavel Pisa; Henric Blomgren; Ingemar Lax; Karl-Mikael Kälkner; Sten Nilsson; Peter Wersäll
Journal:  Acta Oncol       Date:  2006       Impact factor: 4.089

Review 5.  PET in differentiation of recurrent brain tumor from radiation injury.

Authors:  D D Langleben; G M Segall
Journal:  J Nucl Med       Date:  2000-11       Impact factor: 10.057

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.